Catalog No.S2420

For research use only.

Aloperine is an isolated alkaloid in sophora plants such as Sophora alopecuroides L, and exhibits anti-inflammatory, antibacterial, antiviral, and anti-tumor properties.

Aloperine Chemical Structure

CAS No. 56293-29-9

Selleck's Aloperine has been cited by 7 Publications

Purity & Quality Control

Choose Selective Antiviral Inhibitors

Biological Activity

Description Aloperine is an isolated alkaloid in sophora plants such as Sophora alopecuroides L, and exhibits anti-inflammatory, antibacterial, antiviral, and anti-tumor properties.
In vitro

Compared with other alkaloids including sophoridine, sophocarpine, matrine, oxymatrine and cytisine, Aloperine treatment exerts the most potent cytotoxic activity against human cancer cell lines of differing tissue origins, including leukaemia cell lines HL-60, U937 and K562, oesophageal cancer EC109 cells, lung cancer A549 cells and the hepatocellular carcinoma HepG2 cell line with IC50 of 0.04 mM, 0.27 mM, 0.36 mM, 1.11 mM, 1.18 mM, and 1.36 mM, respectively. The strongest cytotoxic effect of Aloperine on HL-60 cells is observed at 72 hours with the inhibition rate of 94.1%.In contrast to the effect on leukaemia cells, up to 1 mM of Aloperine does not significantly reduce the viability of normal PBMNCs at 72 hours. Aloperine treatment at 20 μM for 48 hours significanlty induces apoptosis and autophagy in HL-60 cells in a dose-dependent manner. [2]

In vivo Topical application of 1% Aloperine suppresses 2, 4-dinitrofluorobenzene (DNFB)-induced increase in ear thickness and ear erythema in BALB/c mice, and significantly decreases the up-regulated mRNA and protein levels of tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β) and interleukin-6 (IL-6) induced by DNFB in ear biopsy homogenates. [1] Topical application of Aloperine reduces the DNFB-induced dermatitis (dermatitis index and ear thickness) in NC/Nga mice at day 13 and day 14 in a dose-dependent manner. Aloperine treatment reduces DNFB-induced lymphocytes infiltration and eosinophils infiltration in a dose-dependent manner. Aloperine treatment also reduces the DNFB-induced infiltration of mast cells in a dose-dependent manner. Aloperine reduces the plasma level of IgE in a dose-dependent manner. Aloperine markedly reduces DNFB-induced increase in IL-4, IL-13 and IFN-γ productions, while it increases the IL-10 level in a dose-dependent manner. Aloperine treatment significantly reduces the cytokine levels of TNF-α, IL-1β and IL-6 in ear biopsies homegenates of NC/Nga mice in a dose-dependent manner. [3]

Protocol (from reference)

Cell Research:[2]
  • Cell lines: K562, U937, HL-60, EC109, A549 and HepG2
  • Concentrations: Dissolved in DMSO, final concentrations ~2 mM
  • Incubation Time: 24, 48, and 72 hours
  • Method: Cells are seeded in 96-well plates in 100-μL culture medium. After incubation of 4 hours for leukaemia cells and of 24 hours for solid cancer cells, experimental media containing either excipient control or Aloperine are added to appropriate wells. Five concentrations of Aloperine for 48-hour treatment are used to determine the in vitro IC50 growth inhibitory values of Aloperine in cancer cells. After incubation, 10 μL of MTT solution (5 mg/mL) is added to each well. The plates are then incubated for 4 hours at 37 °C. Intracellular formazan crystals are dissolved by addition of 100 μL of isopropanol-HCI-SDS solution to each well. After an overnight incubation at 37 °C, the optical density of the samples is determined at 570 nm. DNA fragmentation is analysed after the extraction of DNA from cells exposed to the indicated doses of Aloperine for 48 hours using apoptotic DNA ladder kit. For autophagy detection, cells are collected and incubated with PBS containing 5 μM acridine orange for 15 minutes. The acridine orange is removed and the cells are resuspended in 100 μL of PBS. Fluorescent micrographs are obtained with an inverted fluorescent microscope. Autophagy is quantified based on the mean number of cells displaying intense red staining for three fields (containing at least 50 cells per field) for each experimental condition.
Animal Research:[1]
  • Animal Models: Female BALB/c mice with DNFB-induced allergic contact dermatitis
  • Dosages: 1% (w/w)
  • Administration: Topical application

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 232.36


CAS No. 56293-29-9
Storage 3 years -20°C powder
2 years -80°C in solvent

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Aloperine | Aloperine supplier | purchase Aloperine | Aloperine cost | Aloperine manufacturer | order Aloperine | Aloperine distributor